FRA:SNW - Deutsche Boerse Ag - FR0000120578 - Common Stock - Currency: EUR
FRA:SNW (5/22/2025, 7:00:00 PM)
93.43
-0.16 (-0.17%)
The current stock price of SNW.DE is 93.43 EUR. In the past month the price increased by 0.03%. In the past year, price increased by 4.62%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1LLY.MI | ELI LILLY & CO | 52.04 | 600.36B | ||
LLY.DE | ELI LILLY & CO | 51.77 | 597.23B | ||
ZEG.DE | ASTRAZENECA PLC | 18.95 | 383.67B | ||
1JNJ.MI | JOHNSON & JOHNSON | 15.21 | 325.25B | ||
JNJ.DE | JOHNSON & JOHNSON | 15.17 | 324.46B | ||
NOV.DE | NOVO NORDISK A/S-B | 19.35 | 264.57B | ||
RHO.DE | ROCHE HOLDING AG-BR | 14.64 | 238.41B | ||
1SAN.MI | SANOFI | 13.96 | 230.07B | ||
SAN.PA | SANOFI | 13.71 | 225.83B | ||
NOT.DE | NOVARTIS AG-REG | 13.57 | 196.52B | ||
6MK.DE | MERCK & CO. INC. | 9.9 | 171.62B | ||
1MRKX.MI | MERCK & CO. INC. | 9.88 | 171.37B |
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 84,587 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
SANOFI
46 Avenue de la Grande Armee
Paris ILE-DE-FRANCE FR
Employees: 82878
Phone: 33153774000
The current stock price of SNW.DE is 93.43 EUR. The price decreased by -0.17% in the last trading session.
The exchange symbol of SANOFI is SNW and it is listed on the Deutsche Boerse Ag exchange.
SNW.DE stock is listed on the Deutsche Boerse Ag exchange.
29 analysts have analysed SNW.DE and the average price target is 119.33 EUR. This implies a price increase of 27.73% is expected in the next year compared to the current price of 93.43. Check the SANOFI stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SANOFI (SNW.DE) has a market capitalization of 228.72B EUR. This makes SNW.DE a Mega Cap stock.
SANOFI (SNW.DE) currently has 82878 employees.
SANOFI (SNW.DE) has a support level at 92.97 and a resistance level at 95.9. Check the full technical report for a detailed analysis of SNW.DE support and resistance levels.
The Revenue of SANOFI (SNW.DE) is expected to grow by 1.53% in the next year. Check the estimates tab for more information on the SNW.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SANOFI (SNW.DE) has a dividend yield of 4.36%. The yearly dividend amount is currently 3.79. Check the full fundamental report for a detailed analysis of SNW.DE dividend history, reliability and sustainability.
SANOFI (SNW.DE) will report earnings on 2025-07-31, before the market open.
The PE ratio for SANOFI (SNW.DE) is 13.88. This is based on the reported non-GAAP earnings per share of 6.73 and the current share price of 93.43 EUR. Check the full fundamental report for a full analysis of the valuation metrics for SNW.DE.
ChartMill assigns a technical rating of 1 / 10 to SNW.DE. When comparing the yearly performance of all stocks, SNW.DE is a bad performer in the overall market: 66.99% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to SNW.DE. While SNW.DE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Over the last trailing twelve months SNW.DE reported a non-GAAP Earnings per Share(EPS) of 6.73. The EPS decreased by -12.99% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 12.97% | ||
ROA | 9% | ||
ROE | 15.37% | ||
Debt/Equity | 0.17 |
ChartMill assigns a Buy % Consensus number of 80% to SNW.DE. The Buy consensus is the average rating of analysts ratings from 29 analysts.
For the next year, analysts expect an EPS growth of 8.37% and a revenue growth 1.53% for SNW.DE